AU2017200676B2 - Photoprotective compositions comprising synergistic combination of sunscreen active compounds - Google Patents
Photoprotective compositions comprising synergistic combination of sunscreen active compounds Download PDFInfo
- Publication number
- AU2017200676B2 AU2017200676B2 AU2017200676A AU2017200676A AU2017200676B2 AU 2017200676 B2 AU2017200676 B2 AU 2017200676B2 AU 2017200676 A AU2017200676 A AU 2017200676A AU 2017200676 A AU2017200676 A AU 2017200676A AU 2017200676 B2 AU2017200676 B2 AU 2017200676B2
- Authority
- AU
- Australia
- Prior art keywords
- sunscreen
- composition according
- hair
- percent
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 91
- 239000000516 sunscreening agent Substances 0.000 title claims abstract description 66
- 230000000475 sunscreen effect Effects 0.000 title claims abstract description 64
- 230000003711 photoprotective effect Effects 0.000 title claims abstract description 4
- 150000001875 compounds Chemical class 0.000 title description 12
- 239000011885 synergistic combination Substances 0.000 title description 4
- 239000013543 active substance Substances 0.000 claims abstract description 14
- 230000005855 radiation Effects 0.000 claims abstract description 13
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 claims abstract description 10
- 229960002709 amiloxate Drugs 0.000 claims abstract description 10
- 230000000699 topical effect Effects 0.000 claims abstract description 9
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims abstract description 8
- 229960001679 octinoxate Drugs 0.000 claims abstract description 8
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229960000601 octocrylene Drugs 0.000 claims abstract description 8
- 230000002939 deleterious effect Effects 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims abstract description 5
- -1 stick Substances 0.000 claims description 24
- 238000009472 formulation Methods 0.000 claims description 19
- 239000003921 oil Substances 0.000 claims description 19
- 239000002537 cosmetic Substances 0.000 claims description 18
- 235000019198 oils Nutrition 0.000 claims description 18
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 10
- 239000000443 aerosol Substances 0.000 claims description 10
- 230000002195 synergetic effect Effects 0.000 claims description 10
- 239000007921 spray Substances 0.000 claims description 9
- 239000006210 lotion Substances 0.000 claims description 8
- 239000000344 soap Substances 0.000 claims description 8
- 239000006071 cream Substances 0.000 claims description 7
- 239000000839 emulsion Substances 0.000 claims description 7
- 239000011787 zinc oxide Substances 0.000 claims description 7
- 235000014692 zinc oxide Nutrition 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 239000006260 foam Substances 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 239000004166 Lanolin Substances 0.000 claims description 5
- 235000019388 lanolin Nutrition 0.000 claims description 5
- 229940039717 lanolin Drugs 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 235000019271 petrolatum Nutrition 0.000 claims description 5
- 239000002453 shampoo Substances 0.000 claims description 5
- 241000195940 Bryophyta Species 0.000 claims description 4
- 239000004264 Petrolatum Substances 0.000 claims description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 4
- 239000006185 dispersion Substances 0.000 claims description 4
- 235000011929 mousse Nutrition 0.000 claims description 4
- 229940066842 petrolatum Drugs 0.000 claims description 4
- 239000005995 Aluminium silicate Substances 0.000 claims description 3
- 206010015150 Erythema Diseases 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 235000012211 aluminium silicate Nutrition 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 3
- 239000000077 insect repellent Substances 0.000 claims description 3
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 3
- 239000002480 mineral oil Substances 0.000 claims description 3
- 235000010446 mineral oil Nutrition 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 230000037072 sun protection Effects 0.000 claims description 3
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 2
- 208000010201 Exanthema Diseases 0.000 claims description 2
- 239000004909 Moisturizer Substances 0.000 claims description 2
- 241001303601 Rosacea Species 0.000 claims description 2
- 206010062696 Spider vein Diseases 0.000 claims description 2
- 206010052428 Wound Diseases 0.000 claims description 2
- 208000027418 Wounds and injury Diseases 0.000 claims description 2
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 claims description 2
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 claims description 2
- 206010000496 acne Diseases 0.000 claims description 2
- 229960000458 allantoin Drugs 0.000 claims description 2
- 230000003712 anti-aging effect Effects 0.000 claims description 2
- 230000001166 anti-perspirative effect Effects 0.000 claims description 2
- 239000003213 antiperspirant Substances 0.000 claims description 2
- 238000004061 bleaching Methods 0.000 claims description 2
- 229940105847 calamine Drugs 0.000 claims description 2
- 229940052366 colloidal oatmeal Drugs 0.000 claims description 2
- 239000002781 deodorant agent Substances 0.000 claims description 2
- 230000002951 depilatory effect Effects 0.000 claims description 2
- 229940008099 dimethicone Drugs 0.000 claims description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 2
- 201000005884 exanthem Diseases 0.000 claims description 2
- 239000003966 growth inhibitor Substances 0.000 claims description 2
- 230000037308 hair color Effects 0.000 claims description 2
- 230000003779 hair growth Effects 0.000 claims description 2
- 239000008266 hair spray Substances 0.000 claims description 2
- 229940116364 hard fat Drugs 0.000 claims description 2
- 229910052864 hemimorphite Inorganic materials 0.000 claims description 2
- 239000000314 lubricant Substances 0.000 claims description 2
- 230000001333 moisturizer Effects 0.000 claims description 2
- 239000002304 perfume Substances 0.000 claims description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 2
- 206010037844 rash Diseases 0.000 claims description 2
- 201000004700 rosacea Diseases 0.000 claims description 2
- 239000008257 shaving cream Substances 0.000 claims description 2
- 208000009056 telangiectasis Diseases 0.000 claims description 2
- 239000007762 w/o emulsion Substances 0.000 claims description 2
- 239000001993 wax Substances 0.000 claims description 2
- 239000004246 zinc acetate Substances 0.000 claims description 2
- 235000013904 zinc acetate Nutrition 0.000 claims description 2
- 239000011667 zinc carbonate Substances 0.000 claims description 2
- 235000004416 zinc carbonate Nutrition 0.000 claims description 2
- 229910000010 zinc carbonate Inorganic materials 0.000 claims description 2
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims 3
- 239000000725 suspension Substances 0.000 claims 2
- 201000004384 Alopecia Diseases 0.000 claims 1
- 208000003251 Pruritus Diseases 0.000 claims 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims 1
- 206010046996 Varicose vein Diseases 0.000 claims 1
- 229940024546 aluminum hydroxide gel Drugs 0.000 claims 1
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 claims 1
- 235000019868 cocoa butter Nutrition 0.000 claims 1
- 229940110456 cocoa butter Drugs 0.000 claims 1
- 239000003026 cod liver oil Substances 0.000 claims 1
- 235000012716 cod liver oil Nutrition 0.000 claims 1
- 238000005562 fading Methods 0.000 claims 1
- 229960005150 glycerol Drugs 0.000 claims 1
- 208000024963 hair loss Diseases 0.000 claims 1
- 230000003676 hair loss Effects 0.000 claims 1
- 229960000829 kaolin Drugs 0.000 claims 1
- 239000007934 lip balm Substances 0.000 claims 1
- 235000013336 milk Nutrition 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 210000004080 milk Anatomy 0.000 claims 1
- 229940042472 mineral oil Drugs 0.000 claims 1
- 239000007764 o/w emulsion Substances 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 239000006072 paste Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000003871 white petrolatum Substances 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 26
- 239000003795 chemical substances by application Substances 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 239000003380 propellant Substances 0.000 description 12
- 239000011734 sodium Substances 0.000 description 11
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 10
- 235000019441 ethanol Nutrition 0.000 description 10
- 229910052708 sodium Inorganic materials 0.000 description 10
- 239000003974 emollient agent Substances 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 8
- 239000003205 fragrance Substances 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000012530 fluid Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 239000003906 humectant Substances 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 244000044822 Simmondsia californica Species 0.000 description 3
- 235000004433 Simmondsia californica Nutrition 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003607 modifier Substances 0.000 description 3
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 3
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 239000005871 repellent Substances 0.000 description 3
- 230000002940 repellent Effects 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 3
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- NIQCNGHVCWTJSM-UHFFFAOYSA-N Dimethyl phthalate Chemical compound COC(=O)C1=CC=CC=C1C(=O)OC NIQCNGHVCWTJSM-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical compound CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 125000001931 aliphatic group Chemical class 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 239000003212 astringent agent Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- QWTDNUCVQCZILF-UHFFFAOYSA-N isopentane Chemical compound CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- HCZKYJDFEPMADG-TXEJJXNPSA-N masoprocol Chemical compound C([C@H](C)[C@H](C)CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-TXEJJXNPSA-N 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- CRSOQBOWXPBRES-UHFFFAOYSA-N neopentane Chemical compound CC(C)(C)C CRSOQBOWXPBRES-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 125000005474 octanoate group Chemical class 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 230000001846 repelling effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 1
- OQQOAWVKVDAJOI-UHFFFAOYSA-N (2-dodecanoyloxy-3-hydroxypropyl) dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCC OQQOAWVKVDAJOI-UHFFFAOYSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- VHWSRELATOUTAG-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-aminobenzoate Chemical compound NC1=CC=CC=C1C(=O)OCC(O)CO VHWSRELATOUTAG-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- ISDGWTZFJKFKMO-UHFFFAOYSA-N 2-phenyl-1,3-dioxane-4,6-dione Chemical compound O1C(=O)CC(=O)OC1C1=CC=CC=C1 ISDGWTZFJKFKMO-UHFFFAOYSA-N 0.000 description 1
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 1
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- UUGLJVMIFJNVFH-UHFFFAOYSA-N Benzoesaeure-n-hexylester Natural products CCCCCCOC(=O)C1=CC=CC=C1 UUGLJVMIFJNVFH-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 244000166675 Cymbopogon nardus Species 0.000 description 1
- 235000018791 Cymbopogon nardus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 239000001692 EU approved anti-caking agent Substances 0.000 description 1
- 244000182691 Echinochloa frumentacea Species 0.000 description 1
- 235000008247 Echinochloa frumentacea Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical group ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 229920006385 Geon Polymers 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- WLLGXSLBOPFWQV-UHFFFAOYSA-N MGK 264 Chemical compound C1=CC2CC1C1C2C(=O)N(CC(CC)CCCC)C1=O WLLGXSLBOPFWQV-UHFFFAOYSA-N 0.000 description 1
- 241000208467 Macadamia Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 229910000792 Monel Inorganic materials 0.000 description 1
- MMOXZBCLCQITDF-UHFFFAOYSA-N N,N-diethyl-m-toluamide Chemical compound CCN(CC)C(=O)C1=CC=CC(C)=C1 MMOXZBCLCQITDF-UHFFFAOYSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 101150034459 Parpbp gene Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 108010039491 Ricin Proteins 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241001111950 Sonora Species 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- LUTSRLYCMSCGCS-BWOMAWGNSA-N [(3s,8r,9s,10r,13s)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,16-decahydrocyclopenta[a]phenanthren-3-yl] acetate Chemical compound C([C@@H]12)C[C@]3(C)C(=O)CC=C3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)C)C1 LUTSRLYCMSCGCS-BWOMAWGNSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004479 aerosol dispenser Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 150000003868 ammonium compounds Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229940064452 artec Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- LVKZSFMYNWRPJX-UHFFFAOYSA-N benzenearsonic acid Natural products O[As](O)(=O)C1=CC=CC=C1 LVKZSFMYNWRPJX-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- YEAYGXLRPMKZBP-KQGICBIGSA-N bis(2-hydroxyethyl)azanium;(e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound OCCNCCO.COC1=CC=C(\C=C\C(O)=O)C=C1 YEAYGXLRPMKZBP-KQGICBIGSA-N 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- IAQRGUVFOMOMEM-UHFFFAOYSA-N butene Natural products CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- DHAZIUXMHRHVMP-UHFFFAOYSA-N butyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCC DHAZIUXMHRHVMP-UHFFFAOYSA-N 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 1
- 229960001063 cinoxate Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 239000001941 cymbopogon citratus dc and cymbopogon flexuosus oil Substances 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 125000005534 decanoate group Chemical class 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 229940099217 desferal Drugs 0.000 description 1
- IDDIJAWJANBQLJ-UHFFFAOYSA-N desferrioxamine B mesylate Chemical compound [H+].CS([O-])(=O)=O.CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN IDDIJAWJANBQLJ-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229960001673 diethyltoluamide Drugs 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- AFABGHUZZDYHJO-UHFFFAOYSA-N dimethyl butane Natural products CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 1
- FBSAITBEAPNWJG-UHFFFAOYSA-N dimethyl phthalate Natural products CC(=O)OC1=CC=CC=C1OC(C)=O FBSAITBEAPNWJG-UHFFFAOYSA-N 0.000 description 1
- 229960001826 dimethylphthalate Drugs 0.000 description 1
- TVWTZAGVNBPXHU-NXVVXOECSA-N dioctyl (z)-but-2-enedioate Chemical compound CCCCCCCCOC(=O)\C=C/C(=O)OCCCCCCCC TVWTZAGVNBPXHU-NXVVXOECSA-N 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- 229960004960 dioxybenzone Drugs 0.000 description 1
- YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- 229960004697 enzacamene Drugs 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- HCZKYJDFEPMADG-UHFFFAOYSA-N erythro-nordihydroguaiaretic acid Natural products C=1C=C(O)C(O)=CC=1CC(C)C(C)CC1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229910021485 fumed silica Inorganic materials 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940074049 glyceryl dilaurate Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- QAKXLTNAJLFSQC-UHFFFAOYSA-N hexadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC QAKXLTNAJLFSQC-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- RNYJXPUAFDFIQJ-UHFFFAOYSA-N hydron;octadecan-1-amine;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[NH3+] RNYJXPUAFDFIQJ-UHFFFAOYSA-N 0.000 description 1
- 239000003752 hydrotrope Substances 0.000 description 1
- 229940023564 hydroxylated lanolin Drugs 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960003951 masoprocol Drugs 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- SOXAGEOHPCXXIO-DVOMOZLQSA-N menthyl anthranilate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1N SOXAGEOHPCXXIO-DVOMOZLQSA-N 0.000 description 1
- 229960002248 meradimate Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000001455 metallic ions Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- ZHALDANPYXAMJF-UHFFFAOYSA-N octadecanoate;tris(2-hydroxyethyl)azanium Chemical compound OCC[NH+](CCO)CCO.CCCCCCCCCCCCCCCCCC([O-])=O ZHALDANPYXAMJF-UHFFFAOYSA-N 0.000 description 1
- AZJXQVRPBZSNFN-UHFFFAOYSA-N octane-3,3-diol Chemical compound CCCCCC(O)(O)CC AZJXQVRPBZSNFN-UHFFFAOYSA-N 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- 231100000760 phototoxic Toxicity 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 229940076788 pyruvate Drugs 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229920006012 semi-aromatic polyamide Polymers 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical group [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- FGDMJJQHQDFUCP-UHFFFAOYSA-M sodium;2-propan-2-ylnaphthalene-1-sulfonate Chemical compound [Na+].C1=CC=CC2=C(S([O-])(=O)=O)C(C(C)C)=CC=C21 FGDMJJQHQDFUCP-UHFFFAOYSA-M 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-N sodium;5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)NC1=O QGMRQYFBGABWDR-UHFFFAOYSA-N 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229940029614 triethanolamine stearate Drugs 0.000 description 1
- 229940124543 ultraviolet light absorber Drugs 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000004078 waterproofing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Compositions for topical application to skin and/or hair, comprising photoprotecting synergistically effective amounts of sunscreen active agents octinoxate, octocrylene, and amiloxate; methods of protecting skin and/or hair against deleterious effects of sunlight/UV radiation by topical application of compositions.
Description
Phatopratectiw ComposWQOS C&mpHsing
Syn^rgfetie Cbmbioation of Sunscreen Active Compounds
HELP OF THE tWEMTIQH
Th® subject invention is directed to compositions for topical application containing a synergistic combination of sunscreen active compounds, and more particularly to compositions for topical application comprising a synergistic combination of octinoxate, octocrytene, and amiloxate.
BACtCGROOHO OF THE IHyENTW
When applied topically, sunscreen composition®impart a film that protects skin against the damaging effects of exposure to th® sun’s ultreviotet radiation (UVR). Sunscreen active compounds work on skin’s surface by absorbing UVR before ii can interact with and damage skin. A particular ccmpositton's ability to block UVR Is usually expressed in a stm protection factor or SPF rating. Combinations of sunscreen active compounds are typically used in sunscreen composition in order to raise the SPF rating of the composteun.
so U.S. Patent Nos. 6,030,629 and 5,963,461 assert synergistic increase in SPF based on combinations of certain sunscreen active compounds. Further, Andre et al, report a synergistic effect,based on a combination of organic and inorganic sunscreens covering UV-A and UV-B absorption. (V. Andre et at, Cosmetics and Toiletries Manufacture Worldwide 2004, pp. 192s 23.) However, as those authors note, such synergistic increases in SPF are not completely understood, nor is it predictable before hand which combination of compounds will demonstrate a synergistic effect In fact, as demonstrated in the experiments herein, a combination of only two of the three sunscreen actives in the present Invention does not show synergistic an SPF increases*
Thus a cumbination of sunscreen active compounds that demonstrete a synergistic increase in SPF, and thus an enhanced UVR pratectective
2017200676 01 Feb 2017
- 2 ~ capability over what would be pradlcted from their use atone, would be useful and desirable.
These and other objectives are obtained by the invention more fully desoribed and claimed herein.
s
Sy^MARY OF THE IWVEHTIOH
The subject invention provides a topically applicable sunscreen composifion suited for the photoprotection of human skin and/or hair, comprising photopmtechlng synergistically effective amounts of ociinoxate.
io octocry tone, and amiloxate.
The subject invention also provides a cosmetic composition for topical application to human skin and/or hair, comprising photopreteettog synergistically effective amounts of octinoxaie. octocrylene, and amitoxate.
The subject invention further provides a method for protecting human is skin and/or hair against toe deleterious effects of solar radiation, mure particularly ultraviolet radiation (UVR) comprising topically applying thereto an effective amount of the sunscreen compositions as described herein.
DETAILED DESCRIPTION so The subject invention provides a topically applicable sunscreen composition suited for the photoprotectton of human skin and/or hair, comprising phetoprofectfog synetglstlsaliy effective amounts of octinoxate, octocryfene. and amiloxate. Oetfooxate, which fc also known as octyl rnethoxyomnamate or ethylhexyl methoxycinnamate, is listed in Annex VII of a s the EU Cosmetics Directive for use as a sunscreen agent up to a leva! of 10%. In the United States. It is listed by the USFDA for use at level up to 7.5%. Ooiocrylene, whose chemical same is 2-ethylhexyi 2-cyano~3,3~ diphenyl>'2“ptopenaate. is listed by ths USFDA for use up to 10% and in the EU Cosmetics Directive for use up to W%. Amiloxate, whose chemlcsl name
Is 2-beazoic: acid. 2~propenoic s.cid.344mmthaxypheay0~3~methyfoutyi ester and is also known by 4-Methoxycinnamic acidjsoamyl ester or isoamyl p« methoxycinnamate, is being reviewed for approval by the USFDA for use up to 10% and is listed in the EU Cosmetics Directive for use up to 10%. it Is
2017200676 01 Feb 2017 ents sn pn sRtln t'r *£3
2017200676 01 Feb 2017
- 4 ...
propellant, which «pay be any suitable gas. that can be compressed ar liquefied within a spray dispensing canister and which expands orvotefitizes to vapor ar gas form upon exposure to ambient temperature and pressure conditions to deliver the composition in an aerosol form. Suitable propellants include hydrocarbons having 1 to 5 carbon atoms, including but not limited to methane, ethane, propane, isopropane, butane, isobutene, butene, pentane, isopentane, neopentane, pentone, hydrofluorocarbons (HFCs), chlorofluurocafbons(C4“Cs), nitrogen, ethers including dimethyl ether, and any mixtures thereof, Those of ordinary skill in the art recognize that in a dosed container such as an aluminum nan nr glass bottle, propellants such as dimethyl ether condense to the liquid state at ambient temperature. Thus, ths composition in the aerosol container is liquid formulation which ran contain dissolved propellant, undissoived liquid propellant and gaseous propellant Ail of this Is under pressure due to the vapor pressure of the propellant In the
IS practice of the subject Invention, the propellant can be present In an amount up to about 90 weight percent, preferably from about 2 weight percent to about 56 weight percent, and more preferably about 5 weight percent to about 40 weight percent, most preferably 30 weight percent, based an the total weight of the aerosol composition.
uo The compositions of the invention can also comprise aerosol foams pr so-called mousse compositions. For example, U.S, Patent Na, 6,627,585 describes a mousse-forming ofeansing shampoo oompositton comprising a toamable concentrate comprising at least one surfaetant, dispersed partides of a water-insoluble conditioning agent, an aqueous carrier; and an aerosol propellant. U.S. Patent No. 6,284,964 describes a cosmetic composition including a crosslinked non-emulsifying polymtoxana elastomer and a parttoxyvinyi polymer which Is in the form of a n aerosol foam in a pressurised system, The propellant may be introduced Into ths mousse composition at the time of filling by using a standard aerosol dispenser, e.g. a spray can so arrangement
The subject inventfon contemplates the tocurporatton of the synergistic combination of sunscreen actives to sunscreen and sunblock products and any other topically applied composition where file addltiea of sunscreen
2017200676 01 Feb 2017
-5actlve agents would not detract f mm the efficacy of the product nor affect ths sunscreening ability of the sunscreen active agents. Thus the subject invention also provides a cosmetic composition for topical application to human skin and/or hair, comprising photopretectlng synergistically effective amounts of ©ctinoxale, ootacryiena, and amifoxate. Hondimiting examples of such cosmetic compositions may Include such products as moisturizers, cleansers, oonditodem, shampoo, body Wash, styling gsl/lQtinn, eye cmam and aye liner, blush, mascara, foundation, nail polish, polish remover, eye shadow, lipstick, lip gloss, tip liners, lip balms, makeup remover, nail i.o ireatment, foot care compositions, acne treatment, redness/rosacea treatment, variccse/spider vein treatment, anti-aging compositions, sunless tanning compositions, after-sun compositions, conceafers, hair color and bleaching compositfens, skin fadlng/lighfeners, body firming lotion, shaving cream, after shave, rslaxer, antiperspirants and deodorants, exfoliants, is scrubs, liquid hand soap, bubble bath, pain and wound treatment compositions, insect repallani, anthitoh and rash cream, styling mousse and foams, perfume, lubricants, body oil, body spray, baby lotion, diaper cream, baby soap, baby shampoo, baby oil, baby wipes, hairdoss treatment, hair spray, depilatory, hair growth Inhibitors, hair removal waxes, personal go deansing, colognej oil controller, and hand sanitizer.
The compositions of the present invention may contain a wide range of additional, optional components which are referred to herein as cosmetic components’1, but which can also include components generally known as pharmaceutically active agents.. The CTFA Cosmetic Ingredient Handbook, 25 Seventh Edition, 1997 and the Eighth Edition, 205, which is incorporated by reference herein in its entirety, describes a wide variety of cosmetic and pharmaceutical ingredients commonly used in skin care compositions, which are suitable for use in the compositions of the present invention. Examples of these functional classes disclosed in this reference Indude: absorbents, s o abrasives, anticaking agents, antifoaming agents, antioxidants, binders, biological additives, buffering agents, bulking agents, chelating agents, chemical additives, colorants, cosmetic astringents, cosmetic biocides, denaturants, drug astringents, external analgesics, film formers, fragrance
2017200676 01 Feb 2017
- g cbmponants, humectants,, upscifyirw agents, pH adjusters, plasticizers, reducing agents, skin bleaching agents, skin-conditioning agents (emollient, humectants, mlscalteneous, and ocdushte}, skin protectante, solvents, foam boosters, hydrotropes, solubilizing agents, suspendfog agents
S (nonsurfactant), sunscreen agents, ultraviolet light absorbers, SPF boosters, waterproofing agents, and viscosity increasing agents (aqueous and nonaqueous).
In the practice of the foveritium the oomposltten rnay contain one or more sddiftanal sunscreen active agents. For purposes of the present invention, a “sunseraen active agent8 or teunsureen active shall include all of those materials, singly or in combination, that are regarded as acceptable for use as active sunsereenlng fogredtents based on their ability to absorb UV radieton. Such compounds are generally described as being UV-A, UV-β, or UV-A/UV-B active agents. Approval by a regulatory agency is generally is required for inclusion of active agents in formulations intended for human use..
Those active, agents which have been or are currently approved for sunscreen use in the United States include organic and inorganic substances including, without limitation, para aminobenzoic acid, avobanzone, cinoxate, dioxybenzone, homosaiate, menthyl anthranilate, octyl salicylate,
0 oxybenzone, padlmate O, phehyibenzimidazote sulfonic acid, sulisobenzoae, trotamine salicylate, titanium dioxide, zinc oxide, diethanolamine methoxycinnamate, digailoy trioleate, ethyl ditiydmxypropyl PASA, glyceryl aminobenzoate, lawsons with dihydroxyacetone, red petrolatum. Examples of additional sunscreen actives that have not yet been approved in the US but are allowed in formulations sold eutside of the US inoluds ethylhexyl biazene, dioctyl butamidu triazonc, benzylidene malonate polysiloxane, terephthalylidane dlcamphor sulfonic acid, disodium phenyl dibenzimidazote tetrasulfonate, diethytamino hydroxybenzoyl hexyl benzoate, bis dfethylamlno hydroxybenzoyi benzoate, bls benzoxazoylphenyl ethylhexylimino tteine, c drometrizule tnsltoane, methylene bl s-benzatriszolyl tetramethyibutylphenoh and bis-eihylhexyfoxyphenol methoxypHenyitdazine, 4methylbenzylidenecamphor, and isopentyl 4-methoxyclnnamate. However, as the list of approved sunscreens is currently expanding, those ef ordinary skill
2017200676 01 Feb 2017
-7wiil recognize that the invention is not limited to sunscreen active agents currently approved for human use hut is readily applicable to those that may be allowed in the future.
In one embodiment of the inveniinn the add monel sunscreen active
B agent comprises a photeprotecilng effective amount of particulates of at least one inorganic pigment or nanapigment, nondimiting examples of which include titanium dioxide, zinc oxide, iron oxide, zirconium oxide, cerium oxide, or mixture thereof..
The compositions of the invention may also include materials that also io increase the 8PF of the final compmltioa by such mechanisms as UV radiation scattering and dispersion. Such materials are referred to herein as “UV-radiaiion scattering agents” and comprise materials that exhibit UV absorbing activity cr exhibit no UV absorbing activity. An example of such UVvMiaton scattering agents include polymeric materials, such as the is product known as SunSpheres™ (Rohm and Haas; Philadelphia, PA) which are described by their manufacturer as hollow styrane/acrylates copolymer spheres manufactured by emulsion polymerization. The polymer spheres are said to raise SPF values across the UVA and UVB region by dispersing and/or scattering the incident UV radiation throughput the film of sunscreen 20 present on a surface, such as human skin. It is understood that the spheres cause less UV radiation to penetrate into the skin by redirecting the radiation towards the UV~absorbing sunscreen actives In the sunscreen formulation, where ths radiation reacts with the sunscreen active molecules and the energy is dissipated as heat. As used herein, ths terms “spheres” or “scattering agents are not limited by chemical makeup or shape, but comprise any agent that produces te effect of lengthening the path of incident UV radiation, increasing the statistical likelihood that the radiation will contact a sunscreen active molecule, i.e.., a UV absorbing active agent. These materials may also include UV absorbing materials that also exhibit & scattering properties such as ZnO (examples include Z«Cote™ products available from BASF), 11¾ (examples include te Solavsil™ products available from Uniqoma (New Castle, DE. USA]), compounds such as methylene bis-benzotriazclyl tetramethytetyiphenol. (“Ttesorb™ M
2017200676 01 Feb 2017 io
25'
SwiUerfand ). UV
>>
son /i
LfS ί/Ή “'ί'
2017200676 01 Feb 2017
- 9 ~ (40) stearate, polyoxyethylene fatty alcohol ethers such as polyoxyethylene (20) stearyl ether, polyoxyethylene sorbitan fatty add esters such as polyoxyethylene sorbitaa monostearate, sorbitan esters suets as sorbitan monostearate, alkyl glycosides such as cetearyl glucoside, fatty add efhanoiamides and their dehvatives such as the dtethanolamide of stearic add, and the like. Examples of suitabte anionic surfactants are soaps including alkali soaps, such as sodium, potassium and ammonium salts of aliphatic carboxylic adds, usually fatty adds, such as sodium stearate. Organic amine soaps indude organic amine safe of aliphatic carboxylic adds, 10 usually fetty adds, such as triethanolamine stearate. Metallic soaps include salts of polyvalent metals and aliphatic carboxylic acids, usually fatty acids, such as aluminium stearate, Other classes Of suitable anionic surfactants include sulfated fatty add alcohols such as sodium lauryl sulfate, sulfated oils such as the sulfuric ester of rfcinoleic acid disodium sail, and sulfonated is compounds such as alkyl sultanates including sodium cetane sulfonate, amide sulfonates such as sodium N-melhyl-N-oteyl laurate, sulfonated dibasic add esters such as sodium dioctyl sulfosuccinate, alkyl aryl sulfonates such as sodium dodscylbenzen© sulfonate, alkyl nsphthatehe sulfonates such a sodium isopropyl naphthalene sulfonate, petroleum sulfonate such as aryl c nspthalene with alkyl substitutes. Examples of suitable cationic surfactants include amine safe such as octadecyl ammonium chloride, quarternary ammonium compounds such as benzalkonium chloride.
An emollient Is an oleaginous or oily substance which helps to smooth sad soften the skin, and may also reduce its roughness, cracking or Inflation, s s Typical suitable emollients induds mineral oil having a viscosity In the range of 50 to SOU centipoise (cps), lanolin oil, coconut oil, cocoa batten olive oil, almond oil, macadamia out ail, aloo extracts such as aloe vara lipoqulnone, synthetic jojoba oils, natural sonora jojoba oils, safflower oil, corn oil, liquid lanolin, cottonseed Oil and peahut oil Preferably, the emollient is a o cocogiyceride, which is a mixture bf mono, di arid triglycerides of cocoaoil, sold under the trade name of Myritol 331 from Henkel KGaA, or Dlcaprylyl Ether available under the trade name Cetiol GE from Henkel KGaA nr a G«~ C?s Alkyl Benzoate sold under the trade name Rnsolv TN from Rnetex, One
2017200676 01 Feb 2017
-10 or mom emollients may be present ranging In amounts from about 1 percent to about 10 percent by weight, preferably about S percent by weight. Another suftable emollient Is DC 200 Fluid OSO, a silicone fluid, available Dow Coming Corp.
Other suitable emollients indude squalane, castor oil, polybufene, sweet almond nil, avocado oil, catophyllum oil, ricin oil, vitamin E acetate» olive OH, siftcone oils such as dimethytopelysitaane and cyclometoiccne, rteotenic alcohcl, oleyl alcohol, the oil of cereal geons such as the oil of wheat germ, isopropyl palmitate, octyl palmitate, isopropyl myristate, hexadecyl ία stearate, butyl stearate, decyl oleate, acetyl glycerides, the octanoates and bencoates of (C^ -Q{s) alcohols, the octanoates and decanoates of alcohols and polyalcohols such as those of glycol and glyceryl ricincleates esters such as Isopropyl adipate, hexyl laurate and octyl dodecanotee, dicaprylyl maleate, hydrogenated vegetable oil, phenyltrimethluune, jojoba oft and aloe vera is extract
Other suitable emofttenis which are solids or semi-solids at ambient temperatures may be used. Such solid or semi-solid cosmetic emollients include glyceryl dilaurate, hydrogenated lanolin, hydroxylated lanolin, acetylated lanolin.. pmroiatem, isopropyl lanoiate, butyl myristate, cetyl myristate, myristyl myristate, myristyl lactate, cetyl alcohol, isostearyl alcohol and Isecatyl lanolate. One or more emollients can optionally be included In the formulation.
A humectant is a moistening agent that promotes retention of water due to its hygroscopic properties. Suitable humectants include glycerin, s polymeric glycols such as polyethylene glycol and polypropyterm glycol, mannitol and sorbitol Preferably, the humectant is Sorbitol 70¾ USP or polyethylene glycol 400, NF, One or more humectants can optionally be Included to the formulation in amounts from about 1 percent to about TO peroent by weight, preferably about S percent by weight.
A dry-feel modifier is an agent which when added to an emulsion,
Imparts a dry feel to tbs skin when the emuteion dries. Dry feel modifiers can include talc, kaolin, chalk, mnc oxide, silicone fluids, inorganic salts such as barium sulfate, surface treated silica, precipitated silica, fumed silica such
2017200676 01 Feb 2017
-11as an Aerosil available from Oegussa Inc. of New York, N.Y. U.S.A. Another dry feel modifier is an epichlorohydrin cross-linked glyceryl starch of the type that Is di sclosed in U.S. Patent No, 6,488,916.
It may be advantageous to incorporate additional thickening agents, a such as, for instance, various Carbopols available from Novena Co, Particularly preferred are those agents which would not disrupt the lamellar structure in the formulation of the final product, such as nun-ionic thickening agents. The selection of additional Wakening agenta is well within the skill of one in the art.
An tantioxidanU Is a natural or synthetic substance added lathe sunscreen to protect from ar delay its deterioration due to the action of oxygen in ths air (oxidation). They may also reduce oxidation reactions in skin tissue. Anti-oxidants prevent oxidative deterioration which may lead to the generation of rancidity and nonenyxymatic browning reaction products.
is Typical suitable antioxidants Include propyl, octyl and dodecyl esters of gallic acid, butylated hydroxyanisole (BHA, usually purchased as a mixture of ortho and mete isomers). butylated hydroxytoluene· {BUT)., green tea extract, uric acid, cysteine, pyruvate, nordihydroguaiaretic acid, Vitamin A, Vitamin E and Vitamin C and their defiYatives. One or more antioxidanta can optionally be included in the sunscreen composition in an amount ranging horn about 8,001 to about § wight percent, preferably about 0.01 to about 0.8 percent.
Ghclating agents* am substances used to chelate or bind metallic ions, such as with a hetemuyiie ring structure so that ths ion is held by chemical bonds from each of th® participating rings. Suitable chelating agents as include ethylene dlaminetefraacetic add (EDTA), EDTA disodium, calcium dlsodium edefate, EDTA trisodium, albumin, transferrin, desferoxamine, desferal, desferoxamine mesylate, EDTA tetrasodium and EDTA dipotasstam, or combinations of any of these,
Tragtanoes* are aromatic substances which can impart an aesthetically pleasing aroma to ths sunscreen composition, Typical fragrances include aromatic materials extracted from botanical sources (i.e., rose petals, gardenia blossoms, jasmine bowers, etc.) which can be used alone ar in any combination to create essential oils. Alternatively, alcoholic
2017200676 01 Feb 2017 extracts may be prepared for compounding fragrances. However, do© to the relatively high costs of obtaining fragrances from natural substances, the modern trend is to us© synthetically prepared fragrances, particularly in highvolume products, One or more fragrances can optionally be included in the S sunscreen composition in an amount ranging from about 0,001 to about 5 weight percent preferably about<01 to about 0,5 percent by weight Additional preservatives may also be used if desired and include well known preservative compositions such as benzyl alcohol, phenyl ethyl alcohol and benzoic acid, diaznlydinyl, urea, chferphanasi< todoprcpynyl and butyl io carbamate, among others.
The compositions of the invention can further comprise skin protectent active agents. Suitable examples include (with preferred weight percent ranges), Allantoin (0.5 to 2 percent); Aluminum hydroxide gei (0,15 to 5 percent): Calamine (1 to 25 percent); Cocoa bettor (greater than 50); Cod liver is oil (5 to 14 percent); Colloidal oatmeal; Dimethicone (1 to 30 percent);
Glycerin (20 to 45 percent); Hard fat (greater than 50); Kaolin (4 to 20 percent); Landin (12,5 to 50 percent); Mineral oil (greater than 50 percent); Petrolatum (greater than 30 percent); Sodium bicarbonate; Topical starch (10 to 98 percent); While petrolatum (greater than 30 percent); Zinc acetate (0,1 3c to 2 percent); Zinc carbonate (0..2 to 2 percent); and Zinc oxide (1 to 25 percent),
T|ia ecmpcsitiens of the invention may further include insect repelling components. The most widely used insect repelling active agent for personal care products is NiH-DiethyKrn’toiuamide, frequently called *DEET' and as available In the form of a concentrate containing at least about 95 percent DEEx other synthetic ctemical repellents include ethyl butytacetylaniinopropriunate (also known as IR 3535), dimethyl phthalate, ethyl hexanediol, indaione, di-mpnapyllsoclnchoronate, blcyctoheptene, dicarboximide and tetrahydrafuraidehyde. Certain plant-dewed materials 3 c also have insect repellent activity, including dtronefe ail and other sources of citronella (including lemon grass oil), limonene, rosemary oil and eucalyptus oil. Choice of an insect repellent for incorporation into the sunscreen emulsion will frequently be influenced by the odor of the repellent The
2017200676 01 Feb 2017
-13~ amount of repellent agent used will depend upon the choice of agent; DEBT is useful at high conoentrabons. such as up to about 15 percent or more, white some of the plant-derived subsianoee are typically used in much lower amounts, such as 0.1 percent or less,.
s Tepical application of the compositions of the invention described herein to the hair or skin of a human will provide enhanced protection against deleterious effects of ultraviolet radiate (UVR), Thus, the subject invention further provides a method for protecting human skin and/or hair against the defetertous effects of solar radiate, more particularly UVR, whichmethod io comprises topically applying thereto an effective amount of the sunscreen compositions as described herein. An esthetlcaliy beneficial result of exposure of sklh to UVR (I.e., light raditlon wavelengths of from 2SQ nm to 400 nm) is the promotion of tanning of the human epidermis. Another benefit of sun exposure comes from production of vitamin 0 within the skin, UVR is
I S typically divided into UV-A (fight wavelengths from 320 to 400 nm) and UV-B (wavelengths ranging from 28(1 to 320 nm) regions.. Overexposure to UV-B Irradiation is generally understood to lead to skin bums and erythema. In addition, overexposure to UV-A radiation may cause a loss of elasticity of the skin and the appearance of wrinkles, promoting premature skin aging. Such irradiation promotes triggering of the erythemal reaction or amplifies this reaction in certain individuate and may even be the source of phototoxic or photoalterglc reactions. It is increasingly believed that overexposure to UV*A may also lead to melanoma. Thus, the application of the composites of the invention to the skin and/or hair of an individual will provide enhanced UVR
2S phgtoprotectlun (UV-A and/or UV-B) of the skin and/or hair of the individual The compositions of the Invention are intended to provide a sun protection factor (SPF) rating of at least 2, with additional preferable embodiments having a sun protection factor of at least 5, at least 10, at least 15, at least 2,0, at least 25, at least 30, at least 35, at least 40, at least 45, at least 50. and at least 55.
The invention will be further described by means of the following examples. which are not Intended to limit the invention, as defined by the
2017200676 01 Feb 2017 ~ u appended olalms, in any manner
EXAMPLES
Formulation of Sunscreen Lotions
Several oil-in-water formu'attans comprising the sunscreen active compounds amiloxato, octmoxate, and octucrytene, Individually and in various oombinattoris, were tested in to wtoo SPF experimentsk Tables 1 and 2 lst the ingredients for the formulations containing either one or two sunscreen actives io used for comparative purposes* Table 3 contains ingredients for formulations that contain combinations of all three sunscreen setivesf which illustrate the surprising synergy between amiloxafo, octinoxste, and octocrylene. Ail formulations were prepared according to the following general method;
1. Kaltrol and Veegum were added to ths water of Part A in a suitable
1.5 container and mixed with mechanical stirrer rm® completely hydrated. The remainder of the P art A ingredients are then added with mixing to form the water phase and heated to 165-175 'T.
2. In a separate container all of the Part B ingredients are combined and heated to 180-185 β 3. The Part B Ingredients are then added to the water phase of PM A, mixed end cooled slowly to 120-125 *F.
4. The Garmaben II of Part C is then added and mixed well .
5. Tim formulation is then cooled to room temperature and then Part O water is added QB to weight.
2017200676 01 Feb 2017
-ISTable 1
Fwmalatmns Cmrtaintog Single Sunscrew ActW
| IHCI Name | Trade Name | Ex. 1 | Bid 2 | Ex. 3 | Be 4 | Be 5 I | |
| A | Pudifed ww | Water | M75 | 77.25 | 77.25 | 72.25 | 72.25 |
| A | Sodium Cetssryi Sulfeie | Sodium Cetearyl Sulfate | G.30 | 0.3d | 0.30 | « | 0.30 |
| A | Pmpyfehe Giywt | Prapylenss Gley ci | 5.00 | 5.00 = | 5.00 | 5.00 | 5.00 |
| A ; | Magnesium Afemlnum SScale | Vacuum dltra | 1.00 | i.8o | TOO | l.GG | 1.00 [ 0.35 1 |
| : A | ΧοηΤοο Gum | KG&dCGF | 0 35 | 3.35 | 0.35 | 0.35 | |
| j B | WopWyi Glycol Dihspfesrmste | Lexfbsl ‘7 | s.oo | 5.00 | 5.00 | 5.00 | 5.00 |
| B | nvp Eioos&nc Copolymer | GawxVSgSh | 2 GO | 3.00 | 2.00 | 3.00 | W | |
| iir | Araohldyi Alcohol (and) Behenyl Alcohol (arid} Araohidyl Glucoside | Monlonov BOS | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 j |
| B | OcOuoxate | Parscl MCX | 7.50 | 0.00 | b.oo | b.oo | 0.00 |
| B | Amitoxoie | Heoh&Sp» ε-1000 | 0.00 | 5.00 | o.bo | o.ob | W.00 |
| I 8 | Gctocryiena | UvinGNSSS T | G00 | 0.00 | 5.00 | 13.00 | b.ob |
| B | Pcg-30 rsp&iyhydrnxystaafate | Artec®! F 135 | 0 10 | a to | 0.10 | 0.18 | o.lo | |
| B | - DiwdhWne | Bow Coming 208 Fluid. 350 GST | 1.00 | '1.00 | 1.00 | too | too | I |
| C ' | Prnpyiarm glycol (and) Digzolidinyl KBii (end) methyl paraben (and) propyi parabaa | Ger-mahen ll | 1.00 | 1.00 | 1.00 | 1.00 | •log |
| L° | PunhadW&ter | Water | QS | ' as | as | OS | QD |
| I | Wai | 100..00 | 100.00 | 120.00 | ΪΟΟ.ΟΟ | 100.00 1 |
’’ Ah amounts listed as percent by weight.
2017200676 01 Feb 2017
Tabte 2 ftsmwlatimw Containing Two Sbm©re®n Actives-
| pwT | 8NC1 Wame | Trade Hama | Be 8 | Bx.7 | Be 8 | Be 9 I |
| j A L_™ | Atefed Wster | Water | S9.7S | S2.2S | S7J55 | 54.75 |
| Sodium Cstuary? Sulfate | Sodium : CteWyl Sulfate | 0.30 | 0.,30 | 0.3(3 : | 0.30 H | |
| j A | Pmp’yterie Glyfeel | Pmpyiarte Gtoyol | 5.00 | S.OO | 5,90 | 5.00 |
| A | Magnasiura Aluminum Siliauls | Ver-gum Ultra | 1.00 | 1.00 | 1.00 | 1.00 I |
| |™A~~ | Xanthan Gum | OCSF | 0.3S | 9.35 | 0,35 | 0.35 | |
| B | Meopefeyl Glyeai Pihaatenwte | LeXfeal ? | 5.00 | S.OO | 0.00 | 5.00 i |
| B | PVP Oossana Copdiymer | Gbrwx v'-OOO | 2.00 | 2.00 i | 2.00 | 2.00 I |
| 1 B | Araohidyl Alcohol (arid) Beheayl Alcohol (anti) Arachidyi Glycosida | Montanov 202 | 3.00 | 2.00 | 2.00 | 2.,00 I |
| B | Oainoxaie | Pared MGX | 7.00 | 0.00 | 0.00 | 7.50 |
| .Arnsluxate | btebtedtepar-i E- 100(3 | 5,00 | 10.00 | 5.09 | 0 0(3 | | |
| B | Qofeeryfene | Uvinul N 535 T | : 0.0(3 | io.bo | 1(3.00 | 10.00 j |
| B | Fag-30 Dlpolyhytirosiystesrate | Arlacei P 135 | 0.10 | 0..1(1 | 0.1(3 | 0.10 1 |
| [ B | Otatehfeorte | Dow bomfeg 200 Fluid. 350 CST | 1.00 | LOO | 1.60 | 1.00 |
| j c | Propylene giyutil (and) Diasoiidfeyl urea (and) methyi paraben (and) propyl paraben | GenasbmMl | 1.00 | 1.00 | 1.00 | “ΰϊΰΊ |
| 1 b | Funifecl Water- | | Wafer | QS | OS | as | as |
| | | j w | Ϊ 00.00 | 100.00 | : WS 00 | 100 0(3 |
5 Ail amounts listed as percant by weight,
2017200676 01 Feb 2017
| j Fart | IMGI Warn® | Tmcfe H ama | EX, 10 | W. 11 | Bl 121 |
| A | PurGted Water | Water | Ϊ4.75 : | 5S 35 | St. 75 | |
| A | Sorbum Cteteufte Sulfate | Sodium Cotearyi Suifete | o | 0.30 | 0.30 1 |
| A | Prepyteri® Giyete | Propylene Gicyoi | 5.00 | 5,00 | 5.00 |
| A | Masnssium Aluminum OiU3fe | Veepum Gibe | 1.00 | WO | too |
| ί A | Xanthsn Gum | kstwcep | OS | 0.35· | w |
| i B | Neopentyl Glycol 1 fjihapl'teuat® | Lexfeei 7 | 5.00 | 5300 ; | 0.00 : |
| I 8 | PVP Bcosene Copolymer | cswv-sad | zoo | zoo | ZOO 1 |
| | B | Arachldyi Ateohol {and} Sehenyi Alcohol (and) Arechteyl GiiKWid® | Moatenov 302 | 2.00 | 2.00 | 2.00 |
| j B | Gditesxata | Parsec MQX | 7.50 | 7.50 ....................... | 7.50 |
| B | Amfexete | Neoheitepan ts-ioob | 5.00 | 5.00 | 10.00 I |
| B | Gctedrytens | LMrteiNSSGT \ :........ .......____......... | 5.00 | 10.00 | 15.00 i |
| B | P©g-B DipeSytrydroxystearaie | Msto®lP135 | 0.10 | 0,10 | o.wH .... |
| I B | GimetHserte | Daw Coming 200 Fluid, 350 CST | 1.00 | 1.00 | LOO / |
| j <F~ | Propyiaoe glysoi | (and) Dteseildinyl I urea (and) methyl pareben (and) propyl 1 paraben | Garmaben II | 1.00 | LOO , | LOO |
| I 0 | j PurifiedWater | Water | QS | | os | OS |
| |....... | 1 ,L„ . | Total | : 100.00 | 150.00 | 155.00 |
SRF Retirement®
2017200676 01 Feb 2017
-18instructions. Test formulations were applied to the substrates at 2 mg/cmT mounted in 6X7 photographic slide mounts (B&H Photo Video, New York, NY; USA) and atiswed to dry for 20 minutes. An untreated, hydrated Vitru-Skin® substrate was also mounted in a slide mount and stowed to air dry for 20 minutes to serve aS a reference and blank. The In vitro SPF of each formula was determined using an Optomtenca $PF 298$ Analxyer (Optometries LLC, Ayer, MA; USA) equipped with a computer-controlled X-Y sampling stage and operated according to the manufacterer's instruedons. A total of 12 In vitro
PF values were obtained for each formula using a different, non-overlapping io poTtfan on each mounted substrate. The resulting in vitro SPF values are shown in Tabfe 4. AH the SPF values reported ere the average of 12 values measured for each formulation.
Table 4
Measured vs, Expected SPF
| Formula Example | Octinoxate (¾ w/v) | Amlfoxate (%w/v) | Octoorytens (%w/v) :........ .... ....... | Measured SPF(s< | Expected SPF* |
| 1 | 7.5 | 10.5 0.0) | |||
| 2 | — | 5.0 | 8.6(0) ........................... | ||
| 3..... | : --............................. | 5.0 ; | 5.6(0.4) | ' I ; ,.. | |
| 4 | άΛ· | 40 | 15.5 (3,0) | ||
| 8 | — | 10.0 | 13.1 (1.5) | ||
| 7..5 | 5.0 | — | 18.0(1.3) | 19.1 | |
| 7 | A** ................................ | 10.0 | 10.0 | 30.2(3.7) | 28.7 |
| 8 | 5.0 | 10.0 | 24.6 (3.3) | 24.2 | |
| § | 7.5 | 10.0 | 20.5 (3.9) | 26.1 | |
| ΐδ | 7.5 | §43 | 5,0 | 30.0 (2.4) | 24.7 |
| 11 | 7.5 | 5.0 . ....... | ιαΟ | 42.0 (5,9) | 34 7 |
| 12 | 7.5 | 10.0 | 10.0 | 48.2 (5.0) | L2!±- |
’Measured SPF represents Ute mean of three different determinations. ^Expected SPF values reported for Examples 6-12 were calculated by adding the sum of the individual SPF’s from each sunscreen at the sama concentration.
2017200676 01 Feb 2017
-19The results in Table 4 dearly demonstrate that a uhigue synergy exists for the combination of sunscreen actives of the inventibh, .as demonstrated for example io formulas 10-12 containing various levels of all three sunscreen actives. Farmalas 1(M 2 increase SPF values by 5 to 9 SPF' units relative to the SPFs expected tom the arithmetic sum of the SPFs from individual sunscreen actives at the same concentrations. In contrast, measured SPF values of formulas 6-9 containing two sunscreen actives remain about the same as the expected SFF values, confirming that the Synergies observed for x c the combin alien of all three sunscreen actives do not derive from any possible combination of the two sunscreen actives. The synergistic effect in SPF performance only exists for combinations of all three sunscreen actives in the same formula.
In addition to the αΙΜη-water emulsions described above, additional
X c representative examples of photoprctective compositions according to the invention can be made for example as water-inmii emulsions and alcohol spray compositions. Representative Examples 13 (water-in-oil emulsion) and 14 (albohol spray) are described below.
2017200676 01 Feb 2017
-20 -.
Table S
Waiw-m-OO Bmufeton Formulation (Bx. 13)
| Fart | No. | IKCIHamb > | Trade Name | Wt WM | |
| 1 A | 1 | Octlooxste | Rsrfoi MCX | 7,sg |
| 2 : | Amfcxaie | HecHoisopen 6·1 OOP i | W.00 | |
| ( A | 3 | Gutocryteae | URvWNSSQf | 10.00 |
| I A | 4 | Sis-hydroxyetoyoxWmpyl Pimethisenc | OC §SS2 Gafomoi RW i | 4.0Q |
| 1 A | 5 _ | Gyclopenteslteana (end) PBG-12 hlmeihton® Gnmpolyimr | Dow Coming soi 1 Btoxw' : | I |
| S | Tocopherol | ” dJ -alpha tocopherol ....... | ..... 0 20 | |
| { s | 7 | Ateited Water | > Water | 5S.T0 |
| Γ B™ L............... | a | Pmpytene Glycol | Prap^mte GiycN | 5.90 |
| | B | s | Pslyamifioprapyl BigtteNds | -CosmodiCQ | xon I |
| a | IQ | Sodium Chkterte | Sodium Chloride | 0.50 I |
| 11 | Chiorphene^n | 3'(4»ChlQTphenoxyhl .2- Propansdtal | Q.id | | |
| 1 . | Total | 1-30.00 j |
The wteHn-oil fomwhrfon show can be prepared by first adding the oil phase ingredients of part A in a cont^w large enough to hold the entire batch and mixing until uniform. Next. in a separate container add the water of part B followed by th® remaining ingredients of Fart B in the listed order and mix well. Finally, hie water phase of the second step can be added slowly to the oil phase of step one with slow mixing until all of the aqueous phase has been added and then the mixing speed is increased for rapid mixing to complete the emulsification and set the lotion composition.
Tabled
Afcohol Spmy Formulation (Bo14)
2017200676 01 Feb 2017
| M | INCI Name | Trade Home | Wt% (w/w) |
| IA 11 1 | Oclinoxafo ................................... ........................ | Pansol MCX | 7.50 |
| | A Ί2 | Amilbxate | Heohefcpan E~ 1000 | 5.00 |
| A 3 | Gctocryiene | WnW | Έο0™ |
| IA j 4 | Sb Alcohol 40 | SD Alcohol 40 | τΟο j |
| A 5 | Copolymer | bermacryl 79 | 3.00 ί |
| 1A |S | Fragrance .... .................................................... ........ | Fragrance | 0.20 j |
| 1 | | - ........ ' ' ' ' | Total . . | 100.00 j |
s Th® composition is prepared by adding all ingredients to a suitable sized container in ths order listed and mixing untii uniform.. The compositions can then be loaded, for example, info a pump battle for spray application to the skin and/or hair.
io The composslfoha of foe bwontion can afeo be prepared as aerosol formulations for application as a spray to the skin and/or hair. The followim cornposittan in Table 7 (Example 15) Is an example of the production of an aerosei formulation according to the subject invention.
TebteT
Aerosol Lotion Formuiatioo
2017200676 01 Feb 2017
| Pari: | IHGI Hama | Trade Hwie | Wt. % (w/w) | |
| A | Purifed Water | Water | 41.83 | |
| A | Sodium Qni&mys Suited | Sodium Calsaryl Suftele | 0.21 | |
| A | P«3p$ms Giyed | Prcpytens Gteyol | 3.50 | |
| A | &btgn©stem Aluminum Silicate | W&gum ufes | C.ZC | |
| A | Xarxhao Gum | Keitrol CGF | 0.24 | |
| B | PVP Eteosene Copolymer | OanexWdB > | 1.4 i | |
| B | Aractedyi Aicoho> (and) Behenyl Aicoho! {and} Arachidyl Gteotekte | Moutenov SOS | 1Λ | |
| B | dstlncteate | Parsai Μ0Χ ....... ........................... | 5.25 | |
| B | AmSp}®te | Nmtetetetten E-1GGO | 7.GG | |
| B | Qcteoyishc | UvteulOSST | Z..00 | |
| B | W30 Dipclyhydrexystesralc | Artecte P 135 | 0.Q7 | |
| B | Oimethiconc | □dwQhffltep 2G0 Fluid, 350 CST | 0.(0 | |
| : C | Prapytena glycd (and) Plazoildlcyi cma (and) methyl paraben (and) propyl paraben | Germabsa 11 | b.fo | |
| 1 E | Dimethyl Ether | x.x | 30.0 | |
| Total | 103.00...... |
The aerosol Woo .listed in Table 7 can be easily prepared by combining the totion formulatian described herein with a common propellant eno loaded into a suitable container to allow far storage until applied. In the above Example 15/70% of the tdtton described in Example 12 can be combined with a io common propellant, in this case 30% dimethyl ether, In a closed container, such as an aluminum can or glass bottle.
To prepare the aerosol formulation, ths emulsion is allowed to cool to room temperature and then weighed Into ths appropriate conteiner such as an
2017200676 01 Feb 2017
teated •'Φ
It is to be understood that, if any prior art publication is referred to herein, such reference does not constitute an admission that the publication forms a part of the common general knowledge in the art, in Australia or any other country.
n the claims which follow and in the preceding description of the
Invention, except where the context requires otherwise due to express language or necessary implication, the word “comprise” or variations such as “comprises” or “comprising” is used in an inclusive sense, i.e. to specify the presence of the stated features but not to preclude the presence or addition of further features in various embodiments of the invention.
Claims (17)
- The claims defining the invention are as follows:1. A topically applicable sunscreen composition suited for the photo protection of human skin and/or hair, comprising a sunscreen active combination consisting of a synergistic amount of octinoxate, octocrylene, and amiloxate, wherein the sunscreen active combination produces a synergistic increase in the SPF rating of the composition, wherein the octocrylene is present in the combination in an amount from about 5.0 to about 10.0 percent by weight.
- 2. A sunscreen composition according to claim 1, wherein the octocrylene is present in the combination in an amount from about 8.0 to about 10.0 percent by weight.
- 3. A sunscreen composition according to claim 1 or 2, wherein the amiloxate is present in the combination in an amount from about 1.0 to about 10.0 percent by weight.
- 4. A sunscreen composition according to any one of claims 1 to 3, wherein the amiloxate is present in the combination in an amount from about 5.0 to about 10.0 percent by weight.
- 5. A sunscreen composition according to any one of claims 1 to 4, wherein the amiloxate is present in the combination in an amount from about 7.5 to about 10.0 percent by weight.
- 6. A sunscreen composition according to any one of claims 1 to 5, comprising a nonionic vesicle dispersion, emulsion, cream, milk, gel, cream gel, ointment, suspension, dispersion, powder, solid, stick, foam or spray.
- 7. A sunscreen composition according to any one of claims 1 to 6, comprising an anhydrous or aqueous solid or paste, emulsion, suspension, or dispersion.
- 8. A sunscreen composition according to any one of claims 1 to 7, comprising an oil-in-water emulsion.10425644_1 (GHMatters) P80621.AU.22017200676 26 Nov 2018
- 9. A sunscreen composition according to any one of claims 1 to 7, comprising a water-in-oil emulsion.
- 10. A sunscreen composition according to any one of claims 1 to 7, comprising an aerosol formulation.
- 11. A sunscreen composition according to any one of claims 1 to 10, having a sun protection factor of at least 30.
- 12. A cosmetic composition for topical application to human skin and/or hair, containing a combination of sunscreen actives, wherein the sunscreen active agents consist of a synergistically effective amount of octinoxate, octocrylene, and amiloxate present in an amount to produce a synergistic increase in the SPF rating of the composition, wherein the octocrylene is present in the combination in an amount from about 5.0 to about 10.0 percent by weight.
- 13. A cosmetic composition according to claim 12, wherein the composition comprises a moisturizer, a cleanser, a conditioner, a shampoo, a body wash, a styling gel/lotion, an eye cream, an eye liner, a blush, a mascara, a foundation, a nail polish, a polish remover, an eye shadow, a lipstick, a lip gloss, a lip liner, a lip balm, a makeup remover, a nail treatment, a foot care composition, an acne treatment, a redness/rosacea treatment, a varicose/spider vein treatment, an antiaging composition, a sunless tanning composition, an after-sun composition, a concealer, a hair color and a bleaching composition, a skin fading/lightener, a body firming lotion, a shaving cream, an after shave, a relaxer, an antiperspirant, a deodorant, an exfoliant, a scrub, a liquid hand soap, a bubble bath, a pain and a wound treatment, an insect repellant, an anti-itch/rash cream, a styling mousse, a foam, a perfume, a lubricant, a body oil, a body spray, a baby lotion, a diaper cream, a baby soap, a baby shampoo, a baby oil, a baby wipe, a hair-loss treatment, a hair spray, a depilatory, a hair growth inhibitor, a hair removal wax, a personal cleansing, a cologne, an oil controller, ora hand sanitizer.10425644_1 (GHMatters) P80621.AU.22017200676 26 Nov 2018
- 14. A cosmetic composition according to claim 12 or claim 13, further comprising at least one skin protectant active agent.
- 15. A cosmetic composition according to claim 14, wherein said skin protectant active agent comprise allantoin, aluminum hydroxide gel, calamine, cocoa butter, cod liver oil, colloidal oatmeal, dimethicone, glycerin, hard fat, kaolin, lanolin, mineral oil, petrolatum, sodium bicarbonate, topical starch, white petrolatum, zinc acetate, zinc carbonate, and zinc oxide.
- 16. A method for protecting human skin and/or hair against the deleterious effects of ultraviolet solar radiation, comprising topically applying thereto an effective amount of a sunscreen composition according to any one of claims 1 to 11.
- 17. A method for protecting human skin and/or hair against the deleterious effects of ultraviolet irradiation, comprising topically applying thereto an effective amount of the cosmetic composition according to any one of claims 12 to 16.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2017200676A AU2017200676B2 (en) | 2006-10-02 | 2017-02-01 | Photoprotective compositions comprising synergistic combination of sunscreen active compounds |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/541,763 | 2006-10-02 | ||
| AU2007305354A AU2007305354B2 (en) | 2006-10-02 | 2007-09-27 | Photoprotective compositions comprising synergistic combination of sunscreen active compounds |
| AU2014200154A AU2014200154A1 (en) | 2006-10-02 | 2014-01-10 | Photoprotective compositions comprising synergistic combination of sunscreen active compounds |
| AU2017200676A AU2017200676B2 (en) | 2006-10-02 | 2017-02-01 | Photoprotective compositions comprising synergistic combination of sunscreen active compounds |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2014200154A Division AU2014200154A1 (en) | 2006-10-02 | 2014-01-10 | Photoprotective compositions comprising synergistic combination of sunscreen active compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2017200676A1 AU2017200676A1 (en) | 2017-02-16 |
| AU2017200676B2 true AU2017200676B2 (en) | 2018-12-13 |
Family
ID=50001404
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2014200154A Abandoned AU2014200154A1 (en) | 2006-10-02 | 2014-01-10 | Photoprotective compositions comprising synergistic combination of sunscreen active compounds |
| AU2017200676A Ceased AU2017200676B2 (en) | 2006-10-02 | 2017-02-01 | Photoprotective compositions comprising synergistic combination of sunscreen active compounds |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2014200154A Abandoned AU2014200154A1 (en) | 2006-10-02 | 2014-01-10 | Photoprotective compositions comprising synergistic combination of sunscreen active compounds |
Country Status (1)
| Country | Link |
|---|---|
| AU (2) | AU2014200154A1 (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19820660A1 (en) * | 1998-05-08 | 1999-11-18 | Stada Arzneimittel Ag | Stable light-protection gel useful for protecting the skin from ultraviolet radiation |
| US20030091518A1 (en) * | 1999-12-20 | 2003-05-15 | Gilles Pauly | Cosmetic and/or pharmaceutical preparations |
| US20030215405A1 (en) * | 2001-11-12 | 2003-11-20 | Robert Parker | Cosmetic or dermatological light protection agent preparations |
| EP1591104A1 (en) * | 2004-03-17 | 2005-11-02 | Stada Arzneimittel Ag | Use of antioxidants for the preparation of pharmaceutical or cosmetic compositions for protecting the skin from damages by infrared-radiations |
-
2014
- 2014-01-10 AU AU2014200154A patent/AU2014200154A1/en not_active Abandoned
-
2017
- 2017-02-01 AU AU2017200676A patent/AU2017200676B2/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19820660A1 (en) * | 1998-05-08 | 1999-11-18 | Stada Arzneimittel Ag | Stable light-protection gel useful for protecting the skin from ultraviolet radiation |
| US20030091518A1 (en) * | 1999-12-20 | 2003-05-15 | Gilles Pauly | Cosmetic and/or pharmaceutical preparations |
| US20030215405A1 (en) * | 2001-11-12 | 2003-11-20 | Robert Parker | Cosmetic or dermatological light protection agent preparations |
| EP1591104A1 (en) * | 2004-03-17 | 2005-11-02 | Stada Arzneimittel Ag | Use of antioxidants for the preparation of pharmaceutical or cosmetic compositions for protecting the skin from damages by infrared-radiations |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017200676A1 (en) | 2017-02-16 |
| AU2014200154A1 (en) | 2014-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2007305354B2 (en) | Photoprotective compositions comprising synergistic combination of sunscreen active compounds | |
| US20080213192A1 (en) | Aerosol lotion formulations | |
| US10241121B2 (en) | Method of selecting antioxidants for use in topically applied compositions | |
| US8303940B2 (en) | Photostabilization of octyl triazone | |
| CA2886063A1 (en) | Foaming skincare formulations | |
| BR112020000940A2 (en) | sunscreen formulation. | |
| AU2017200676B2 (en) | Photoprotective compositions comprising synergistic combination of sunscreen active compounds | |
| HK1148070A (en) | Method of selecting antioxidants for use in topically applied compositions | |
| HK1148070B (en) | Method of selecting antioxidants for use in topically applied compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| PC | Assignment registered |
Owner name: BEIERSDORF AG Free format text: FORMER OWNER(S): BAYER CONSUMER CARE AG |
|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |